Search Results - "Magnusson, JO"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Early Childhood Overweight and Asthma and Allergic Sensitization at 8 Years of Age by ÖHMAN MAGNUSSON, Jessica, KULL, Inger, MAI, Xiao-Mei, WICKMAN, Magnus, BERGSTROM, Anna

    Published in Pediatrics (Evanston) (2012)
    “…Our aim was to examine the associations between high BMI and changes in BMI status during the first 7 years of life and asthma and allergic sensitization at…”
    Get full text
    Journal Article
  2. 2

    Wine drinking is associated with increased heart rate variability in women with coronary heart disease by Janszky, I, Ericson, M, Blom, M, Georgiades, A, Magnusson, J-O, Alinagizadeh, H, Ahnve, S

    Published in Heart (British Cardiac Society) (01-03-2005)
    “…Objective: To test the hypothesis that alcohol consumption is positively related to heart rate variability (HRV) in women with coronary heart disease (CHD) and…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cells by Gustafsson, T, Andersson, P, Chen, Y, Magnusson, J O, Arnqvist, H J

    Published in The American journal of physiology (01-08-1999)
    “…We studied the effects and interactions of ANG II and the insulin-like growth factor (IGF) system in cultured rat aortic smooth muscle cells. ANG II (1 microM)…”
    Get full text
    Journal Article
  6. 6

    Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo by Chen, Y., Capron, L., Magnusson, J.O., Wallby, L.A., Arnqvist, H.J.

    Published in Growth hormone & IGF research (01-08-1998)
    “…IGF-I is a mitogen for vascular smooth muscle cells (SMC) in vitro and enhances SMC proliferation in vivo in diabetic rats. In this study, we examined the…”
    Get full text
    Journal Article
  7. 7

    A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group by Grip, L, Frison, L, Wallentin, L, Dellborg, M, Grande, P, Halinen, M, Myhre, E, Ryden, L, Swahn, E, Swedberg, K, Thygesen, K, Naslund, U, FischerHansen, J, Barret, M, Nilsson, JE, TegerNilsson, AC, Lundstrom, M, Hildebrand, A, deFlonOlsson, C, Isberg, P, Larsson, C, Norgaard, B, Klarlund, K, Landorph, A, Agner, E, Helqvist, S, Rasmussen, SL, Egstrup, K, Sajadieh, A, Gill, S, Haghfelt, T, Thomassen, A, Fischer, T, Kiilavuori, K, Nurminen, J, Melin, J, Koskela, E, Hurme, H, Vauhonen, I, Honkanen, T, Hamalainen, T, Lilja, M, Ukkolva, O, Kivela, H, PohjolaSintonen, S, Hussi, E, Larsen, A, Paulsen, A, Holm, T, Edvardsen, T, Thybo, NK, Kapelrud, H, Waage, K, Hammarstrom, E, Astrom, L, Wettervik, C, Forsberg, SA, Fredriksson, B, Maru, F, Nilsson, H, Akrawi, S, Ahlberg, G, Linde, B, Gustafsson, G, Larsson, AC, Andersen, K, Kierkegaard, A, Hardhammar, P, Landgren, F, Ryden, S, Weiner, L, Danielewicz, M, Malmros, B, Nicol, P, Ohlin, H, Hansen, O, Tingberg, E, Nyman, I, Ahlstrom, P, Hedback, B, Svennberg, L, Ellstrom, J, Remmets, J, Kristensson, BE, Linder, R, Hulting, J, Hoijer, J, Lycksell, M, Wahlin, M, Sandstedt, L, Redfors, A, Borretzen, J, Ostberg, G, Johansson, B, Lindahl, B, Oldgren, J, Jonsson, J, Sinnerstad, B, Larsson, LE, Band, S

    Published in European heart journal (01-09-1997)
    “…Unstable coronary artery disease, i.e. unstable angina or non-Q wave myocardial infarction, is caused by rupture of atheromatous plaques initiating thrombus…”
    Get full text
    Journal Article
  8. 8

    Metabolism of digoxin after oral and intrajejunal administration by Magnusson, JO

    Published in British journal of clinical pharmacology (01-12-1983)
    “…To study the influence of administration site on metabolism of digoxin in the gut, urinary excretion of digoxin and its metabolites was compared after oral and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Metabolism of digoxin and absorption site by Magnusson, JO, Bergdahl, B, Bogentoft, C, Jonsson, UE

    Published in British journal of clinical pharmacology (01-08-1982)
    “…After oral intake of enteric‐coated granules containing [3H]‐digoxin extensive metabolism was observed. Maximum 66% of the 24 h urinary excretion was…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetics of chlorazepate after intravenous and intramuscular administration by Bertler, A, Lindgren, S, Magnusson, J O, Malmgren, H

    Published in Psychopharmacology (01-01-1983)
    “…Dichlorazepate (DPC) was given to eight healthy volunteers aged 22-38 years (five males and three females). The dose was 20 mg (48.9 mumol) given either as an…”
    Get full text
    Journal Article
  12. 12

    Determination of tritiated digoxin and metabolites in urine by liquid chromatography by Eriksson, B M, Tekenbergs, L, Magnusson, J O, Molin, L

    Published in Journal of chromatography (08-05-1981)
    “…A liquid chromatographic method for the determination of digoxin, digoxigenin, its mono- and bisdigitoxoside and dihydrodigoxin in urine is described. Doses of…”
    Get more information
    Journal Article
  13. 13

    Intramuscular bioavailability of chlorazepate as compared to diazepam by BERTLER, A, LINDGREN, S, MAGNUSSON, J.-O, MALMGREN, H

    Published in European journal of clinical pharmacology (01-01-1985)
    “…Dipotassium chlorazepate (DPC) and diazepam (DZM) were given i.m. and i.v. to 6 healthy volunteers in doses of 20 mg (48.9 mumol) DPC and 15 mg (52.0 mumol)…”
    Get full text
    Journal Article
  14. 14

    Absorption of digoxin from a new microencapsulated formulation by Bergdahl, B, Bogentoft, C, Jonsson, U E, Magnusson, J O

    Published in European journal of clinical pharmacology (01-06-1980)
    “…The absorption of digoxin from two capsule preparations containing a large number of small, enteric-coated granules of the glycoside (0.38 mg) was compared…”
    Get full text
    Journal Article
  15. 15

    Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin by MAGNUSSON, J. O, BERGDAHL, B, BOGENTOFT, C, GUSTAFSSON, S, JONSSON, U. E

    Published in European journal of clinical pharmacology (01-01-1984)
    “…A capsule preparation containing small, enteric-coated granules of digoxin was developed to prevent acid hydrolysis of the drug in the stomach and to diminish…”
    Get full text
    Journal Article
  16. 16

    Fasting and postprandial absorption of digoxin from a microencapsulated formulation by BERGDAHL, B, BOGENTOFT, C, JONSSON, U. E, MAGNUSSON, J. O

    Published in European journal of clinical pharmacology (01-01-1983)
    “…The absorption of digoxin from a capsule preparation containing a large number of small, enteric-coated granules of the glycoside (Preparation CR) was compared…”
    Get full text
    Journal Article
  17. 17

    Excretion of digoxin and its metabolites in urine after a single oral dose in healthy subjects by Magnusson, J O, Bergdahl, B, Bogentoft, C, Jonsson, U E, Tekenbergs, L

    Published in Biopharmaceutics & drug disposition (01-07-1982)
    “…The 3-day urinary excretion of digoxin, its conjugated and unconjugated hydrolytic metabolites and dihydrodigoxin, was studied in 8 healthy men after oral…”
    Get more information
    Journal Article
  18. 18

    Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study by Bergdahl, B, Karlsson, E, Magnusson, J O, Sonnhag, C

    Published in Acta medica Scandinavica (01-01-1978)
    “…Patients with suspected or proven acute myocardial infarction complicated by ventricular arrhythmias not corrected by lidocaine therapy (bolus dose 100 mg…”
    Get more information
    Journal Article
  19. 19

    Urinary excretion of digoxin and its metabolites in hyperacidic patients and in patients during coronary care by Magnusson, J O, Bergdahl, B, Gustafsson, S

    Published in Arzneimittel-Forschung (1984)
    “…The hydrolytic cleavage of digoxin was studied after single oral doses of tritiated glycoside to four patients with gastric hyperacidity (GH-group) and to six…”
    Get more information
    Journal Article